Kleinostheim, Germany

Christian Brenneis

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v., Other. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Brenneis. Retrieved from https://idiyas.com/inventor/christian-brenneis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christian Brenneis: Innovator in Pain Management and Cartilage Treatment

Introduction

Christian Brenneis is a notable inventor based in Kleinostheim, Germany. He has made significant contributions to the field of pain management and cartilage treatment through his innovative patents. With a total of 2 patents, Brenneis is recognized for his work in developing novel therapeutic approaches.

Latest Patents

One of his latest patents focuses on CYP2J2 antagonists in the treatment of pain. This invention pertains to novel treatments for neuropathic pain, particularly chemotherapy-induced peripheral neuropathic pain (CIPNP). The invention provides antagonists of cytochrome P450 epoxygenases (CYP), specifically targeting CYP2J2 as therapeutics for alleviating CIPNP. These antagonists have been identified to reduce chemotherapeutic-induced pain, allowing for higher dosing during cancer treatment. Additionally, the invention explores the use of CYP2J2 agonists or metabolites for sensitizing TRPV1, proposing combinations of these agents to treat disorders responsive to TRPV1 agonists.

Another significant patent involves a fusion protein comprising an FGF-18 moiety. This invention relates to new fusion proteins that combine an FGF-18 moiety with an anti-NGF moiety. The resulting fusion protein can be utilized for treating cartilage disorders, such as osteoarthritis or cartilage injury.

Career Highlights

Christian Brenneis has worked with prominent organizations, including the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. His experience in research and development has significantly influenced his innovative contributions to medical science.

Collaborations

Throughout his career, Brenneis has collaborated with notable colleagues, including Sebastian Zinn and Thomas Rysiok. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in healthcare.

Conclusion

Christian Brenneis stands out as an inventor dedicated to advancing treatments for pain and cartilage disorders. His innovative patents reflect his commitment to improving patient outcomes through scientific research and collaboration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…